"Designing Growth Strategies is in our DNA"

Psoriasis Treatment Market Size, Share & Industry Analysis, By Drug Class (TNF Inhibitors, Interleukins Inhibitors, and Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, and Others), By Product Type (Biologics and Non-Biologics), By Route of Administration (Oral, Parenteral/Systemic, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI100600

 

  1. Introduction
    1. Market Scope
    2. Market Segmentation
    3. Market Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Psoriasis, By Key Countries, 2023
    2. Overview: Regulatory Scenario & Reimbursement Scenario, By Key Countries/Region
    3. New Product Launches, By Key Players
    4. Pipeline Analysis, By Key Players
    5. Key Industry Developments, By Key Players
    6. Impact of COVID-19 on the Market
  5. Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. TNF Inhibitors
      2. Interleukins Inhibitors
      3. Others
    2. Market Analysis, Insights and Forecast – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1. Biologics
      2. Non-Biologics
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral/Systemic
      3. Topical
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. TNF Inhibitors
      2. Interleukins Inhibitors
      3. Others
    2. Market Analysis, Insights and Forecast – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1. Biologics
      2. Non-Biologics
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral/Systemic
      3. Topical
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast  – By Country
      1. U.S.
        1. By Type
      2. Canada
        1. By Type
  7. Europe Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. TNF Inhibitors
      2. Interleukins Inhibitors
      3. Others
    2. Market Analysis, Insights and Forecast – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1. Biologics
      2. Non-Biologics
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral/Systemic
      3. Topical
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. U.K
        1. By Type
      2. Germany
        1. By Type
      3. France
        1. By Type
      4. Spain
        1. By Type
      5. Italy
        1. By Type
      6. Scandinavia
        1. By Type
      7. Rest of Europe
        1. By Type
  8. Asia Pacific Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. TNF Inhibitors
      2. Interleukins Inhibitors
      3. Others
    2. Market Analysis, Insights and Forecast – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1. Biologics
      2. Non-Biologics
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral/Systemic
      3. Topical
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Japan
        1. By Type
      2. China
        1. By Type
      3. India
        1. By Type
      4. Australia & New Zealand
        1. By Type
      5. Rest of Asia Pacific
        1. By Type
  9. Latin America Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. TNF Inhibitors
      2. Interleukins Inhibitors
      3. Others
    2. Market Analysis, Insights and Forecast – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1. Biologics
      2. Non-Biologics
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral/Systemic
      3. Topical
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. Brazil
        1. By Type
      2. Mexico
        1. By Type
      3. Rest of Latin America
        1. By Type
  10. Middle East & Africa Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. TNF Inhibitors
      2. Interleukins Inhibitors
      3. Others
    2. Market Analysis, Insights and Forecast – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    3. Market Analysis, Insights and Forecast – By Product Type
      1. Biologics
      2. Non-Biologics
    4. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral/Systemic
      3. Topical
    5. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Analysis, Insights and Forecast  – By Country/Sub-region
      1. GCC
        1. By Type
      2. South Africa
        1. By Type
      3. Rest of Middle East & Africa
        1. By Type
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. AbbVie Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. Novartis AG
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. LEO Pharma A/S
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. Merck & Co., Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Amgen Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Eli Lilly and Company
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      9. Evelo Biosciences, Inc.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      10. UCB S.A.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      11. Sun Pharmaceutical Industries Ltd.
        1. Overview
        2. Products & Services
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 1: Global Psoriasis Treatment Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 2: Global Psoriasis Treatment Market Value Share (%), by Drug Class, 2023 & 2032

Figure 3: Global Psoriasis Treatment Market Value Share (%), by Type, 2023 & 2032

Figure 4: Global Psoriasis Treatment Market Value Share (%), by Product Type, 2023 & 2032

Figure 5: Global Psoriasis Treatment Market Value Share (%), by Route of Administration, 2023 & 2032

Figure 6: Global Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2023 & 2032

Figure 7: Global Psoriasis Treatment Market Value (USD billion), by Region, 2023 & 2032

Figure 8: North America Psoriasis Treatment Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 9: North America Psoriasis Treatment Market Value Share (%), by Drug Class, 2023

Figure 10: North America Psoriasis Treatment Market Value (USD billion), by Type, 2023 & 2032

Figure 11: North America Psoriasis Treatment Market Value Share (%), by Type, 2023

Figure 12: North America Psoriasis Treatment Market Value (USD billion), by Product Type, 2023 & 2032

Figure 13: North America Psoriasis Treatment Market Value Share (%), by Product Type, 2023

Figure 14: North America Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 15: North America Psoriasis Treatment Market Value Share (%), by Route of Administration, 2023

Figure 16: North America Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 17: North America Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2023

Figure 18: North America Psoriasis Treatment Market Value (USD billion), By Country, 2023 & 2032

Figure 19: North America Psoriasis Treatment Market Value Share (%), By Country, 2023

Figure 20: Europe Psoriasis Treatment Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 21: Europe Psoriasis Treatment Market Value Share (%), by Drug Class, 2023

Figure 22: Europe Psoriasis Treatment Market Value (USD billion), by Type, 2023 & 2032

Figure 23: Europe Psoriasis Treatment Market Value Share (%), by Type, 2023

Figure 24: Europe Psoriasis Treatment Market Value (USD billion), by Product Type, 2023 & 2032

Figure 25: Europe Psoriasis Treatment Market Value Share (%), by Product Type, 2023

Figure 26: Europe Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 27: Europe Psoriasis Treatment Market Value Share (%), by Route of Administration, 2023

Figure 28: Europe Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 29: Europe Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2023

Figure 30: Europe Psoriasis Treatment Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 31: Europe Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2023

Figure 32: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 33: Asia Pacific Psoriasis Treatment Market Value Share (%), by Drug Class, 2023

Figure 34: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Type, 2023 & 2032

Figure 35: Asia Pacific Psoriasis Treatment Market Value Share (%), by Type, 2023

Figure 36: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Product Type, 2023 & 2032

Figure 37: Asia Pacific Psoriasis Treatment Market Value Share (%), by Product Type, 2023

Figure 38: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 39: Asia Pacific Psoriasis Treatment Market Value Share (%), by Route of Administration, 2023

Figure 40: Asia Pacific Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 41: Asia Pacific Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2023

Figure 42: Asia Pacific Psoriasis Treatment Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 43: Asia Pacific Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2023

Figure 44: Latin America Psoriasis Treatment Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 45: Latin America Psoriasis Treatment Market Value Share (%), by Drug Class, 2023

Figure 46: Latin America Psoriasis Treatment Market Value (USD billion), by Type, 2023 & 2032

Figure 47: Latin America Psoriasis Treatment Market Value Share (%), by Type, 2023

Figure 48: Latin America Psoriasis Treatment Market Value (USD billion), by Product Type, 2023 & 2032

Figure 49: Latin America Psoriasis Treatment Market Value Share (%), by Product Type, 2023

Figure 50: Latin America Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 51: Latin America Psoriasis Treatment Market Value Share (%), by Route of Administration, 2023

Figure 52: Latin America Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 53: Latin America Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2023

Figure 54: Latin America Psoriasis Treatment Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 55: Latin America Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2023

Figure 56: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Drug Class, 2023 & 2032

Figure 57: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Drug Class, 2023

Figure 58: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Type, 2023 & 2032

Figure 59: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Type, 2023

Figure 60: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Product Type, 2023 & 2032

Figure 61: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Product Type, 2023

Figure 62: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Route of Administration, 2023 & 2032

Figure 63: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Route of Administration, 2023

Figure 64: Middle East & Africa Psoriasis Treatment Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 65: Middle East & Africa Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2023

Figure 66: Middle East & Africa Psoriasis Treatment Market Value (USD billion), By Country/ Sub-region, 2023 & 2032

Figure 67: Middle East & Africa Psoriasis Treatment Market Value Share (%), By Country/ Sub-region, 2023

Figure 68: Global Psoriasis Treatment Market Share (%), By Company, 2023

Table 1: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019–2032

Table 2: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019–2032

Table 3: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2019–2032

Table 4: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2032

Table 5: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2032

Table 6: Global Psoriasis Treatment Market Revenue (USD billion) Forecast, by Region, 2019-2032

Table 7: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 8: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 9: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2019-2032

Table 10: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 11: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 12: North America Psoriasis Treatment Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 13: U.S. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 14: Canada Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 15: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 16: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 17: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2019-2032

Table 18: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 19: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 20: Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 21: U.K. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 22: Germany Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 23: France Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 24: Italy Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 25: Spain Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 26: Scandinavia Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 27: Rest of Europe Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 28: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 29: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 30: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2019-2032

Table 31: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 32: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 33: Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 34: China Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 35: India Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 36: Japan Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 37: Australia & New Zealand Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 38: Rest of Asia Pacific Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 39: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 40: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 41: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2019-2032

Table 42: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 43: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 44: Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 45: Brazil Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 46: Mexico Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 47: Rest of Latin America Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 48: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019-2032

Table 49: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 50: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Product Type, 2019-2032

Table 51: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2019-2032

Table 52: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032

Table 53: Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

Table 54: GCC Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 55: South Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

Table 56: Rest of Middle East & Africa Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019-2032

  • 2019-2032
  • 2023
  • 2019-2022
  • 166
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase